Role
About
Paul Reynolds is Clinical Director, Heart and Lung Program, Central Adelaide Local Health Network (overseeing Respiratory Medicine, Cardiology and Cardiothoracic Surgery) and Director, Lung Research Laboratory, University of Adelaide. He has overseen the CREATE program promoting the development of early career researchers in the previous CRE. Paul has been a member of the steering committee of the Australian IPF Registry since its inception and has co-authored several publications with the national IPF investigators. These include NHMRC funded projects in the investigation of biomarkers in IPF, and national management guidelines for both IPF and connective tissue related ILDs. He is now a member of the steering committee for the ILD Registry. In his own laboratory he has worked on the development of gene and cell therapies for pulmonary vascular disease and pulmonary fibrosis, focusing on TGFb related pathways. This work involves cellular biology approaches using outgrowth endothelial cells from patients, and state of the art animal models. Clinical Research work includes involvement in industry sponsored trials and investigator -initiated studies including the GRIPF study investigating genetic mechanisms involved in familial IPF and the Telescope study investigating a novel approach to treatment for short telomere associated ILDs.
Paul Reynolds has national roles as a board director of the Lung Foundation of Australia and as a member of the RACP Advanced Training Committee for Respiratory and Sleep Medicine. He conducts accreditation site visits to hospitals nationally ensuring the quality of RACP training. He also conducts a busy clinical practice encompassing all aspects of Respiratory and Sleep medicine, but with a particular interest in ILDs, PAH and Lung Cancer, and is an active participant in the MDTs covering these conditions. He is a former President of the TSANZ and recipient of the TSANZ Society Medal for contribution to the profession.